Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

× No keyword cloud information.

69 in total

1. Insulin-sensitising agents in polycystic-ovary syndrome.

Authors: N Sattar; Z E Hopkinson; I A Greer
Journal: Lancet Date: 1998-01-31 Impact factor: 79.321

2. Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder?

Authors: R L Rosenfield
Journal: Clin Endocrinol (Oxf) Date: 1997-10 Impact factor: 3.478

3. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome.

Authors: C Gilling-Smith; H Story; V Rogers; S Franks
Journal: Clin Endocrinol (Oxf) Date: 1997-07 Impact factor: 3.478

4. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.

Authors: A E Taylor; B McCourt; K A Martin; E J Anderson; J M Adams; D Schoenfeld; J E Hall
Journal: J Clin Endocrinol Metab Date: 1997-07 Impact factor: 5.958

5. Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays.

Authors: V Imse; G Holzapfel; B Hinney; W Kuhn; W Wuttke
Journal: J Clin Endocrinol Metab Date: 1992-05 Impact factor: 5.958

6. [Do androgens modulate luteinizing hormone secretion in women?].

Authors: T Sir
Journal: Rev Med Chil Date: 1997-06 Impact factor: 0.553

7. Hormonal effects of flutamide in young women with polycystic ovary syndrome.

Authors: V De Leo; D Lanzetta; D D'Antona; A la Marca; G Morgante
Journal: J Clin Endocrinol Metab Date: 1998-01 Impact factor: 5.958

8. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism.

Authors: S G Levrant; R B Barnes; R L Rosenfield
Journal: Hum Reprod Date: 1997-07 Impact factor: 6.918

9. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.

Authors: B C Fauser; T D Pache; S W Lamberts; W C Hop; F H de Jong; K D Dahl
Journal: J Clin Endocrinol Metab Date: 1991-10 Impact factor: 5.958

10. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.

Authors: A Arroyo; G A Laughlin; A J Morales; S S Yen
Journal: J Clin Endocrinol Metab Date: 1997-11 Impact factor: 5.958

3 in total

1. The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.

Authors: Chuan Xing; Han Zhao; Jiaqi Zhang; Bing He
Journal: Front Physiol Date: 2022-05-09 Impact factor: 4.755

2. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).

Authors: Maha H Daghestani; Mazin Daghestani; Mamoon Daghistani; Akmal El-Mazny; Geir Bjørklund; Salvatore Chirumbolo; Samar H Al Saggaf; Arjumand Warsy
Journal: Lipids Health Dis Date: 2018-08-21 Impact factor: 3.876

3. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review

Authors: Elif Günalan; Aylin Yaba; Bayram Yılmaz
Journal: J Turk Ger Gynecol Assoc Date: 2018-10-09

3 in total